
Tom Brady Becomes Latest Athlete To Promote GLP-1 Drugs as Health Experts Question Move
When news broke this week that former NFL quarterback Tom Brady would become the new Chief Wellness Officer for eMed Population Health — promoting medically supervised weight-loss drugs including GLP-1 therapies — it drew immediate buzz. But not everyone is celebrating the move.


















































